Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperglycaemia during hospitalisation].

T M Vriesendorp1, J H de Vries, J B L Hoekstra

  • 1Academisch Medisch Centrum/Universiteit van Amsterdam, afd. Inwendige Geneeskunde, Secretariaat F4-222, Meibergdreef 9, 1105 AZ Amsterdam. t.m.vriesendorp@amc.uva.nl

Nederlands Tijdschrift Voor Geneeskunde
|July 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Systematic Review and Expert Evaluation of Perioperative SGLT2 Inhibitor-Associated Ketoacidosis Case Reports.

Acta anaesthesiologica Scandinavica·2026
Same author

[Time to stop sliding scale insulin regimen].

Nederlands tijdschrift voor geneeskunde·2024
Same author

Systematic review of functional outcome and quality of life after total pancreatectomy.

The British journal of surgery·2019
Same author

Fatty acid intake and its dietary sources in relation with markers of type 2 diabetes risk: The NEO study.

European journal of clinical nutrition·2016
Same author

Add-on treatment with intermediate-acting insulin versus sliding-scale insulin for patients with type 2 diabetes or insulin resistance during cyclic glucocorticoid-containing antineoplastic chemotherapy: a randomized crossover study.

Diabetes, obesity & metabolism·2016
Same author

Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial.

Diabetes, obesity & metabolism·2015
Same journal

[Insulin intoxications caused by falsified semaglutide].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Professional skepticism in medical research].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Improving mobility in painful osteoarthritis].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The effectiveness and costs of the Back At work After Surgery (BAAS) work-integrated care pathway on return to work for patients receiving knee arthroplasty].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The rise of genetic therapies: urgent moral and societal questions].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[A man with a wound on his elbow].

Nederlands tijdschrift voor geneeskunde·2026
See all related articles

Strictly controlling blood-glucose levels with intensive insulin therapy improves survival rates for intensive care unit patients. This approach benefits surgical and non-surgical patients, including those with cardiac surgery, myocardial infarction, or stroke.

Area of Science:

  • Intensive care medicine
  • Endocrinology
  • Metabolic disorders

Context:

  • Critically ill patients admitted to intensive care units (ICUs) for extended periods.
  • Patients undergoing major surgery, particularly cardiac procedures.
  • Individuals experiencing acute cardiovascular events like myocardial infarction or ischemic stroke.

Purpose:

  • To evaluate the impact of intensive insulin therapy on survival rates in ICU patients.
  • To assess the efficacy of strict glycemic control in reducing complications and mortality in specific patient populations.
  • To determine the established benefits of treating hyperglycemia in various clinical settings.

Summary:

  • Intensive insulin therapy for strict blood-glucose control in ICU patients (≥3 days) is associated with increased survival.

Related Experiment Videos

  • Strict peri- and postoperative glycemic management in cardiac surgery patients reduces complications and potentially mortality.
  • Patients with acute myocardial infarction and possibly acute ischemic stroke may benefit from tight glycemic control, though benefits in other groups remain unproven.

    • Impact:

    • Improved patient outcomes and survival in critical care settings through optimized glycemic management.
    • Potential reduction in healthcare costs associated with fewer complications and shorter ICU stays.
    • Highlights the need for further research to define optimal glycemic targets and treatment durations for diverse patient cohorts.